Skip to content

Clinical trials

Active, not recruiting Triple Negative Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Active, not recruiting Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20103
20121
20131
20141
20159
201611
201711
20189
201917
202015
202115
202219
20239
202416
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting144

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
M.D. Anderson Cancer Center7
AstraZeneca5
Gilead Sciences4
Massachusetts General Hospital4
Memorial Sloan Kettering Cancer Center4
City of Hope Medical Center3
Fudan University3
UNICANCER3
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms144
Breast Neoplasms59
Carcinoma, Non-Small-Cell Lung25
Ovarian Neoplasms21
Melanoma17
Squamous Cell Carcinoma of Head and Neck15
Carcinoma, Renal Cell13
Neoplasm Metastasis13
Colorectal Neoplasms12
Neoplasms12

Trials

Showing 76 to 100 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.